Clinical Trials
10 trialsNCT03508180 2025-12-19
REFYO-R
Hospices Civils de Lyon
Phase NA Completed
NCT00179348 2023-05-31
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Albert Einstein College of Medicine
Phase NA Completed
NCT04430842 2023-01-18
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Phase 1 Completed
NCT03571126 2021-07-13
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer
Zunyi Medical College
Phase 4 Unknown
NCT00003685 2020-04-03
Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT04201769 2020-04-03
LUNG-NEPA
Consorzio Oncotech
Phase 3 Unknown
NCT00253708 2017-08-07
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
Beth Israel Deaconess Medical Center
Phase NA Completed
NCT02445872 2015-12-09
Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy
Zhejiang University
Phase 2 Unknown
NCT00891761 2015-04-17
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
GlaxoSmithKline
Phase 3 Withdrawn
NCT02407600 2015-04-03
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
State University of New York - Upstate Medical University
Phase 2 Unknown